The market for treating vaginal and vulval inflammatory illnesses is set to experience significant growth in the coming years. According to recent projections, the market is expected to reach a value of USD 2.96 billion in fiscal year 2023, up from USD 2.8 billion in the previous year. This upward trend is projected to continue, …